Mednet Logo
HomeRadiation OncologyQuestion

How do you approach SRS for brain metastases in the setting of a connective tissue disorder such as lupus or scleroderma?

1
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Columbia University Irving Medical Center

Historically, connective tissue disorders (CTD) have been considered to be a relative contraindication to radiotherapy generally - due to concerns of potential increased risk of complications. Data on this issue is somewhat conflicting. In the setting of SRS for brain metastases or brain tumors, the...

Register or Sign In to see full answer

How do you approach SRS for brain metastases in the setting of a connective tissue disorder such as lupus or scleroderma? | Mednet